Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sberbank reported for 6 months of 2023 by IFRS

8/3/23 SBER

Beluga Group reported for 6 months of 2023 by RAS

8/3/23 BELU

Energy Transfer reported for 6 months of 2023

8/3/23 ET

PayPal has reported for 6 months of 2023

8/3/23 PYPL

Gas production at Yamal LNG slipped by a third

8/3/23 NVTK

Qualcomm reported for 9 months of fiscal 2023

8/3/23 QCOM

Rostelecom buys 35% of Megacampus educational platform

8/3/23 RTKM

Genetico reported for 6 months of 2023 by RAS

8/2/23 GECO

Moscow Exchange summarized results of trading in July

8/2/23 MOEX

Norinickel reported for 6 months of 2023 by IFRS

8/2/23 GMKN